pharma · Colorectal Neoplasms · Borderline Resectable Pancreatic Adenocarcinoma
Zhejiang Rongyao Biotech
Zhejiang University
Zhejiang Rongyao Biotech clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- CN
- Founded
- 1999
- Employees
- 5
- Programs
- 2
- Drugs
- 3
- Patents
- 0
Zhejiang Rongyao Biotech projects
2 ClinicalTrials.gov programs sponsored by Zhejiang Rongyao Biotech.
Zhejiang Rongyao Biotech has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Zhejiang Rongyao Biotech have?
2 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.